Clinical Trial Update: Efficacy Study of the Effect of Budesonide on Emphysema [Phase 4]

View source ↗

Summary

A Phase 4 efficacy study evaluating budesonide for emphysema associated with COPD has completed, sponsored by AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• Pulmicort (budesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED